{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:00:27Z","timestamp":1773910827818,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031212","name":"Network of European Institutes for Advanced Study","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006022","name":"French Government Ministry of Social Affairs Health and Womens Rights","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.arcped.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:23:54Z","timestamp":1760138634000},"page":"532-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-5604","authenticated-orcid":false,"given":"Julie","family":"Haesebaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9957-3672","authenticated-orcid":false,"given":"Stephanie","family":"Poupon-Bourdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Nouvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-8335","authenticated-orcid":false,"given":"Philippe","family":"Reix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2025.08.001_bib0001","first-page":"160","article-title":"Cystic fibrosis of the pancreas","volume":"1","author":"Di Sant'Agnese","year":"1948","journal-title":"Prog Pediat Study"},{"key":"10.1016\/j.arcped.2025.08.001_bib0002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(16)00053-9","article-title":"Newborn screening for cystic fibrosis","volume":"4","author":"Castellani","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arcped.2025.08.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.10","article-title":"Cystic fibrosis","volume":"1","author":"Ratjen","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.arcped.2025.08.001_bib0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arcped.2025.08.001_bib0005","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/ppul.25627","article-title":"Review of CFTR modulators 2020","volume":"56","author":"Goetz","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arcped.2025.08.001_bib0008","article-title":"The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant","volume":"61","author":"Burgel","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2025.08.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00110-2023","article-title":"Theratyping cystic fibrosis patients to guide elexacaftor\/tezacaftor\/ivacaftor out-of-label prescription","volume":"62","author":"Dreano","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2025.08.001_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcf.2023.03.018","article-title":"Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: a retrospective review","volume":"23","author":"Guenther","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2025.08.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102248","article-title":"Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis","volume":"82","author":"Tiotiu","year":"2023","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.arcped.2025.08.001_bib0012","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic Fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2025.08.001_bib0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/thoraxjnl-2020-216265","article-title":"Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials","volume":"77","author":"Keogh","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.arcped.2025.08.001_bib0014","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/ppul.26527","article-title":"Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: healthcare providers' observations across US centers","volume":"58","author":"Bathgate","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arcped.2025.08.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","volume":"62","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2025.08.001_bib0016","article-title":"Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease","volume":"80","author":"Martin","year":"2021","journal-title":"Respir Med Res"},{"key":"10.1016\/j.arcped.2025.08.001_bib0017","doi-asserted-by":"crossref","first-page":"n2061","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2025.08.001_bib0018","article-title":"Guidance on how to develop complex interventions to improve health and healthcare","volume":"9","author":"O'Cathain","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.arcped.2025.08.001_bib0019","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/109019819802500502","article-title":"Intervention mapping: a process for developing theory- and evidence-based health education programs","volume":"25","author":"Bartholomew","year":"1998","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.arcped.2025.08.001_bib0020","series-title":"Planning health promotion programs: An intervention mapping approach","first-page":"704","author":"Bartholomew","year":"2016"},{"key":"10.1016\/j.arcped.2025.08.001_bib0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12889-018-5329-5","article-title":"Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program","volume":"18","author":"Koutoukidis","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arcped.2025.08.001_bib0022","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1090198117709885","article-title":"Use of intervention mapping to enhance health care professional practice: a systematic review","volume":"44","author":"Durks","year":"2017","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.arcped.2025.08.001_bib0023","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1186\/s12889-023-17311-1","article-title":"Using a theoretical framework of Intervention mapping to inform public health communication messages designed to increase vaccination uptake; the example of mpox in the Netherlands","volume":"23","author":"Evers","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arcped.2025.08.001_bib0024","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/02813432.2023.2268674","article-title":"General practitioners' stay-at-work practices in patients with musculoskeletal disorders: using Intervention Mapping to develop a training program","volume":"41","author":"Moller","year":"2023","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.arcped.2025.08.001_bib0025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/tbm\/ibad063","article-title":"Using intervention mapping to design and implement a multicomponent intervention to improve antibiotic and NSAID prescribing","volume":"13","author":"Reese","year":"2023","journal-title":"Transl Behav Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X25001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:29:57Z","timestamp":1773894597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X25001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0929693X25001721"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2025.08.001","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie.","name":"copyright","label":"Copyright"}]}}